Entheon Biomedical (TSE:ENBI) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Canadian biotech firm Entheon Biomedical is launching a private placement financing to raise up to CDN$300,000 by issuing 3 million units, each consisting of a common share and a warrant. The proceeds will be used for general working capital, providing potential growth opportunities for the company focused on addiction treatment.
For further insights into TSE:ENBI stock, check out TipRanks’ Stock Analysis page.